14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
JGH vs KIO: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
JGH Captures Overall Composite Edge (40.9 SELL vs 37.2 SELL), While KIO Leads 1–0 on Growth & Valuation Pillars
JGH Overall Winner
6-Pillar Tally: JGH 0 – 1 KIO (5 Tie)
Matrix Metrics: JGH 3 – 1 KIO
As of Nov 16, 2026, Nuveen Global High Income Fund (JGH) captures the overall head-to-head institutional edge over Kkr Income Opportunities Fund (KIO) on higher Unified Composite conviction (40.9/100 SELL vs. 37.2/100 SELL) after splitting the core matrix 3–1 (led by composite factor balance), while KIO wins 1–0 across the 6-pillar growth and valuation breakdown. JGH trades at $11.38 (N/M Forward P/E, N/A operating margin) versus KIO at $9.79 (N/M Forward P/E, N/A operating margin).
Growth vs. Quality Trade-Off: JGH earns the overall head-to-head edge with a stronger Unified Composite Score (40.9/100 SELL vs. KIO 37.2/100 SELL) and 0.42β · 10% Vol risk profile, whereas KIO leads top-line expansion (N/A YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
Defensive Composite Rating Caution: Although JGH compares more favorably head-to-head, both JGH (40.9/100 SELL) and KIO (37.2/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: JGH is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 40.6); meanwhile KIO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on JGH vs KIO. Trailing 12-month operating profitability (JGH N/A vs KIO N/A) and valuation multiples (JGH N/M vs KIO N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with $312.7M market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
KIO Moat ProfileCyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with $514.2M market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ JGH vs KIO Key Questions & Quantitative Answers
As of Nov 16, 2026, Nuveen Global High Income Fund (JGH) captures the overall head-to-head institutional edge over Kkr Income Opportunities Fund (KIO) on higher Unified Composite conviction (40.9/100 SELL vs. 37.2/100 SELL) after splitting the core matrix 3–1 (led by composite factor balance), while KIO wins 1–0 across the 6-pillar growth and valuation breakdown. JGH trades at $11.38 (N/M Forward P/E, N/A operating margin) versus KIO at $9.79 (N/M Forward P/E, N/A operating margin). Growth vs. Quality Trade-Off: JGH earns the overall head-to-head edge with a stronger Unified Composite Score (40.9/100 SELL vs. KIO 37.2/100 SELL) and 0.42β · 10% Vol risk profile, whereas KIO leads top-line expansion (N/A YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates. Defensive Composite Rating Caution: Although JGH compares more favorably head-to-head, both JGH (40.9/100 SELL) and KIO (37.2/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: JGH is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 40.6); meanwhile KIO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
KIO leads the Growth & Scale pillar: JGH posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with KIO at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, JGH generates N/A in USD-normalized revenue versus N/A for KIO. In operating R&D and SG&A reinvestment, JGH deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for KIO.
JGH and KIO trade at balanced relative valuation multiples. JGH trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas KIO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against JGH (N/A ROE) versus KIO (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, JGH carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.42β · 10% Vol realized risk). By comparison, KIO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.51β · 13% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.